Ignite Creation Date:
2025-12-24 @ 7:03 PM
Ignite Modification Date:
2026-01-22 @ 5:34 AM
Study NCT ID:
NCT03076957
Status:
UNKNOWN
Last Update Posted:
2017-03-10
First Post:
2016-12-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj.
Sponsor:
Chong Kun Dang Pharmaceutical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12
Start Date Type:
None
Primary Completion Date:
2018-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-06
Completion Date Type:
ESTIMATED
First Submit Date:
2016-12-22
First Submit QC Date:
None
Study First Post Date:
2017-03-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-06
Last Update Post Date:
2017-03-10
Last Update Post Date Type:
ACTUAL